Your browser doesn't support javascript.
loading
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease.
Vilariño-Güell, Carles; Zimprich, Alexander; Martinelli-Boneschi, Filippo; Herculano, Bruno; Wang, Zhe; Matesanz, Fuencisla; Urcelay, Elena; Vandenbroeck, Koen; Leyva, Laura; Gris, Denis; Massaad, Charbel; Quandt, Jacqueline A; Traboulsee, Anthony L; Encarnacion, Mary; Bernales, Cecily Q; Follett, Jordan; Yee, Irene M; Criscuoli, Maria G; Deutschländer, Angela; Reinthaler, Eva M; Zrzavy, Tobias; Mascia, Elisabetta; Zauli, Andrea; Esposito, Federica; Alcina, Antonio; Izquierdo, Guillermo; Espino-Paisán, Laura; Mena, Jorge; Antigüedad, Alfredo; Urbaneja-Romero, Patricia; Ortega-Pinazo, Jesús; Song, Weihong; Sadovnick, A Dessa.
Affiliation
  • Vilariño-Güell C; Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
  • Zimprich A; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Martinelli-Boneschi F; Laboratory of Human Genetics of Neurological Disorders, CNS Inflammatory Unit, Institute of Experimental Neurology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Herculano B; MS Unit and Department of Neurology, IRCCS Policlinico San Donato, Milan, Italy.
  • Wang Z; Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
  • Matesanz F; Townsend Family Laboratories, Department of Psychiatry, University of British Columbia, Vancouver, Canada.
  • Urcelay E; Townsend Family Laboratories, Department of Psychiatry, University of British Columbia, Vancouver, Canada.
  • Vandenbroeck K; National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of the Capital Medical University, Beijing, China.
  • Leyva L; Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina López Neyra (IPBLN), CSIC, Granada, Spain.
  • Gris D; Immunology Dept, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
  • Massaad C; Red Española de Esclerosis Múltiple REEM, Madrid, Spain.
  • Quandt JA; Achucarro Basque Center for Neuroscience, Universidad del País Vasco (UPV/EHU), Leioa, Spain.
  • Traboulsee AL; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.
  • Encarnacion M; Red Española de Esclerosis Múltiple REEM, Madrid, Spain.
  • Bernales CQ; Instituto de Investigación Biomédica de Málaga-IBIMA, Unidad de Gestion Clínica de Neurociencias, Hospital Regional Universitario de Málaga, Málaga, Spain.
  • Follett J; Division of Immunology, Department of Pediatrics, CR-CHUS, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Canada.
  • Yee IM; Toxicology, Pharmacology and Cell Signalisation-UMR-S 1124 Université Paris Descartes, Paris, France.
  • Criscuoli MG; Department of Pathology, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Deutschländer A; Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Reinthaler EM; Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
  • Zrzavy T; Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
  • Mascia E; Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
  • Zauli A; Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
  • Esposito F; Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
  • Alcina A; Department of Neurology, Mayo Clinic Florida, Jacksonville, FL, United States of America.
  • Izquierdo G; Department of Clinical Genomics, Mayo Clinic Florida, Jacksonville, FL, United States of America.
  • Espino-Paisán L; Department of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, United States of America.
  • Mena J; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Antigüedad A; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Urbaneja-Romero P; Laboratory of Human Genetics of Neurological Disorders, CNS Inflammatory Unit, Institute of Experimental Neurology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Ortega-Pinazo J; Laboratory of Human Genetics of Neurological Disorders, CNS Inflammatory Unit, Institute of Experimental Neurology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Song W; Laboratory of Human Genetics of Neurological Disorders, CNS Inflammatory Unit, Institute of Experimental Neurology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Sadovnick AD; Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina López Neyra (IPBLN), CSIC, Granada, Spain.
PLoS Genet ; 15(6): e1008180, 2019 06.
Article de En | MEDLINE | ID: mdl-31170158
ABSTRACT
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system characterized by myelin loss and neuronal dysfunction. Although the majority of patients do not present familial aggregation, Mendelian forms have been described. We performed whole-exome sequencing analysis in 132 patients from 34 multi-incident families, which nominated likely pathogenic variants for MS in 12 genes of the innate immune system that regulate the transcription and activation of inflammatory mediators. Rare missense or nonsense variants were identified in genes of the fibrinolysis and complement pathways (PLAU, MASP1, C2), inflammasome assembly (NLRP12), Wnt signaling (UBR2, CTNNA3, NFATC2, RNF213), nuclear receptor complexes (NCOA3), and cation channels and exchangers (KCNG4, SLC24A6, SLC8B1). These genes suggest a disruption of interconnected immunological and pro-inflammatory pathways as the initial event in the pathophysiology of familial MS, and provide the molecular and biological rationale for the chronic inflammation, demyelination and neurodegeneration observed in MS patients.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Prédisposition génétique à une maladie / Transcriptome / Inflammation / Sclérose en plaques Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: PLoS Genet Sujet du journal: GENETICA Année: 2019 Type de document: Article Pays d'affiliation: Canada

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Prédisposition génétique à une maladie / Transcriptome / Inflammation / Sclérose en plaques Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: PLoS Genet Sujet du journal: GENETICA Année: 2019 Type de document: Article Pays d'affiliation: Canada
...